EdgarLookup
DEF 14A

DEF 14A Filing

Company
Insight Molecular Diagnostics Inc.
Filed
May 21, 2021
Period of Report
May 21, 2021
Accession Number
0001493152-21-012508

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →